April 03, 2026 04:01 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
AAP drops Raghav Chadha from key parliamentary role, sparks buzz over internal rift | Amit Shah to camp in West Bengal for 15 days during Assembly polls; predicts Mamata’s defeat in state and Bhabanipur | 'BJP plotting President’s Rule, don’t fall in the trap': Mamata Banerjee on Malda unrest, urges peace | 'Most polarised state': CJI Kant raps Bengal govt over 9-hour hostage of judicial officers | Bengal SIR protest: Judge pleads for help amid mob attack after 9-hour hostage ordeal | Bengal SIR progress: 47 lakh of 60 lakh adjudicated cases disposed of, Supreme Court informed | Amit Shah to join Suvendu Adhikari on Bhabanipur nomination day; BJP plans mega roadshow | Fuel prices rise: Premium petrol, diesel hiked amid oil price surge | Commercial LPG up Rs 195.50 as global oil prices rise; domestic rates unchanged | Layoff alert: Oracle cuts 30,000 jobs globally, 12,000 hit in India
Canada
Image credit: Wikimedia Commons

Health Canada approves Moderna’s updated COVID-19 vaccine for Omicron variant

| @indiablooms | Sep 03, 2022, at 05:03 am

Toronto/IBNS: Moderna’s updated COVID-19 vaccine targeting the Omicron variant has been formally approved by Health Canada.

This vaccine has been approved for use in adults and will become the first COVID-19 vaccine available in Canada that targets Omicron in addition to the original strain of the coronavirus.

Health Canada said in a decision summary made public Thursday, that the new vaccine shows “significantly higher responses” to the Omicron BA.1 virus in comparison to Moderna’s original coronavirus vaccine, officially branded as Spikevax.

Although the updated vaccine was developed to target the Omicron BA.1 variant, clinical trials, says Health Canada suggest the new vaccine still shows a stronger immune response against the more recent mutations of Omicron — BA.4 and BA.5 — which are now dominant.

According to recommendations of the National Advisory Committee on Immunization (NACI) the updated vaccine should be offered to adults who are recommended to receive a fall booster dose.

NACI says that the vaccine could also be offered to adolescents between 12 and 17 with “moderately to severely immunocompromising conditions” and those who have elevated social risk factors.

(Reporting by Asha Bajaj)

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.